{"id":453822,"date":"2019-12-04T17:32:01","date_gmt":"2019-12-04T17:32:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=453822"},"modified":"2019-12-04T17:32:01","modified_gmt":"2019-12-04T17:32:01","slug":"gene-editing-market-major-players-analysis-crispr-genscript-usa-horizon-discovery-integrated-dna","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/gene-editing-market-major-players-analysis-crispr-genscript-usa-horizon-discovery-integrated-dna_453822.html","title":{"rendered":"Gene Editing Market Major Players Analysis – CRISPR, GenScript USA, Horizon Discovery, Integrated DNA"},"content":{"rendered":"
\"Gene<\/a><\/p>\n
\n
Gene Editing Global Market Report 2019<\/div>\n<\/div>\n<\/div>\n
Integrated DNA Technologies Is One Of The Largest Companies In The Gene Editing Market, According To TBRC\u2019s Report
\n(Companies: CRISPR, GenScript USA Inc., Horizon Discovery Group plc, Integrated DNA Technologies and New England Biolabs)\n<\/div>\n

The global gene editing market was valued at about $3.49 billion in 2018. <\/em>The gene editing market consists of sales of gene editing technology such as CRISPR\/CAS9, zinc finger nucleus, and talens and related services. Gene editing technology allows genetic material to change genetic code at particular location in a genome. It involves cell line engineering, animal genetic engineering and plant genetic engineering.<\/p>\n

Browse Complete Report With TOC @<\/strong> https:\/\/www.thebusinessresearchcompany.com\/report\/gene-editing-global-market-report<\/a><\/p>\n

The global gene editing market is expected to grow to $6.05 billion at a rate of about 14.7% through 2022. The rising number of infectious diseases acts as one of the major drivers of the gene editing market. Gene editing techniques are used for detection of infectious diseases such as HIV. Infectious diseases are caused by microorganisms like bacteria, viruses, fungi, and parasites. Gene therapy treats the infectious diseases by blocking the replication of the infectious agent that causes the disease at the extracellular level. Gene editing introduces new genetic material into the cells of living organisms with the intention of treating the diseases.<\/p>\n

Ethical issues in general public with respect to gene editing is one of the major restraining factors for the market. The emergence of advanced genome editing techniques is one of the major trends in the gene editing market. The new techniques in genome editing are relatively inexpensive and can be used in a variety of application areas such as improving the food supply in agriculture, rectifying specific genetic mutations in the human genome and preventing the spread of diseases.<\/p>\n

Major players in the market are CRISPR, GenScript USA Inc., Horizon Discovery Group plc, Integrated DNA Technologies and New England Biolabs. Integrated DNA Technologies, Inc., headquartered in Coralville, Iowa, is a supplier of custom nucleic acids, serving the areas of academic research, biotechnology, clinical diagnostics, and pharmaceutical development.<\/p>\n

Request a Sample @<\/strong> https:\/\/www.thebusinessresearchcompany.com\/sample.aspx?id=2486&type=smp<\/a> <\/strong><\/p>\n

 <\/p>\n

Few List of Tables and Figuers: <\/strong><\/p>\n

Table 1:<\/span> Global Historic Market Growth, 2014-2018, $ Billion<\/span><\/strong><\/p>\n